Kaken Pharmaceutical Co., Ltd. (4521) Press Release
[Summary] Consolidated Financial Results for the Three-Months Period of Fiscal 2026 (Three-Month Period Ended June 30, 2026) [JGAAP]
Earlier from Kaken Pharmaceutical
- Kaken Pharmaceutical: Consolidated Financial Results for the Fiscal Year 2025
- Kaken Pharmaceutical: Supplementary Financial Information of Financial Statements Fiscal 2025
- KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update
- Kaken Pharmaceutical: Consolidated Financial Results for the Nine Months Period of Fiscal 2025 (Nine Month Period Ended December 31, 2025)